VolitionRx secures lender waiver for above-cap ATM equity sales under convertible debt dealPUBT·2 days ago, 08:46 PMVNRX-0.09%
VolitionRx issues 4,698,628 shares to Lind Global on note conversions under private placement exemptionPUBT·Sep 2 at 10:06 AMVNRX-0.09%
Weekly Recap | Volitionrx +7.77%, Sysmex deal drives volume spikeWeekly Review·Aug 29 at 06:34 AMVNRX-0.09%
VolitionRx tumbles 9% in after-hours trading after 47% intraday surgeUS Stock Market Update·Aug 27 at 11:31 PMVNRX-0.09%
VolitionRx Surges 70% as H1 Revenue Jumps 112% on Nu.Q ProgressUS Stock Market Update·Aug 27 at 06:19 PMVNRX-0.09%
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga_article·Aug 27 at 05:06 PMAPUS-3.59%PPCB-0.98%
VolitionRx surges 71% as H1 revenue jumps 112%, Nu.Q platform advancesUS Stock Market Update·Aug 27 at 02:58 PMVNRX-0.09%
VolitionRx surges 77% on 112% revenue jump, sepsis diagnostics progressUS Stock Market Update·Aug 27 at 01:34 PMVNRX-0.09%
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga_article·Aug 27 at 12:05 PMACIU-2.39%VNRX-0.09%
Penny Stock VolitionRx Expands Addressable Markets With Key Diagnostic Validationsbenzinga_article·Aug 27 at 11:35 AMVNRX-0.09%
U.S. stock night market volatility: VolitionRx surged 28.15% in after-hours trading, boosted by Sysmex collaboration and doubled revenuePrice Alert·Aug 27 at 04:00 AMVNRX-0.09%
VolitionRx shares are trading lower. The company announced the publication of a peer‑reviewed paper and editorial showing its Nu.Q NETs H3.1 biomarker predicts 28‑day mortality and need for renal replacement therapy in sepsis patients.benzinga_article·Aug 26 at 04:23 PMVNRX-0.09%
VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets | VNRX Stock NewsStockTitan·Aug 26 at 05:17 AMVNRX-0.09%SSMXY-0.24%